Home Newsfeeds Credit Suisse Downgrades Zebra Technologies to Neutral, Lowers Price Target to $313

Credit Suisse Downgrades Zebra Technologies to Neutral, Lowers Price Target to $313

Credit Suisse analyst Guy Hardwick downgrades Zebra Technologies (NASDAQ:ZBRA) from Outperform to Neutral and lowers the price target from $319 to $313.

byBenzinga Newsdesk

February 9, 2023

1 minute read

Credit Suisse analyst Guy Hardwick downgrades Zebra Technologies (NASDAQ:ZBRA) from Outperform to Neutral and lowers the price target from $319 to $313.

News

MyMD Pharmaceuticals Filing From Late Monday Shows Co. Entered Omnibus Waiver And Amendment Agreement With Required Holders Under Previously Announced Securities Purchase Agreement

By Benzinga Newsdesk

April 9, 9:30 AM

As previously disclosed, on February 21, 2023, MyMD Pharmaceuticals, Inc. (the "Company") entered into a Securities Purchase Agreement (the "Purchase Agreement") with certain accredited investors (the "Holders") pursuant

MYMD

John Marshall Bancorp Q4 EPS $0.58 Up From $0.54 YoY

By Benzinga Newsdesk

January 18, 10:09 AM

John Marshall Bancorp (NASDAQ:JMSB) reported quarterly earnings of $0.58 per share. This is a 7.41 percent increase over earnings of $0.54 per share from the same period last year.

JMSB

‘Rich Dad Poor Dad’ Author Robert Kiyosaki Unveils His Bitcoin Strategy Amid Market Crash: ‘The Best Time To Get Rich’

By Benzinga Neuro

May 3, 12:33 AM

Robert Kiyosaki, the author of the best-selling book “Rich Dad Poor Dad,” has shared his strategy for navigating the ongoing Bitcoin (CRYPTO: BTC) market crash, highlighting the potential for wealth growth during such periods.

BTC